Centiva Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.6M | Buy |
899,074
+383,579
| +74% | +$10M | 0.19% | 98 |
|
|
2026
Q1 | $14.5M | Buy |
515,495
+243,137
| +89% | +$6.47M | 0.11% | 135 |
|
|
2025
Q4 | $6.78M | Sell |
272,358
-117,580
| -30% | -$2.97M | 0.06% | 212 |
|
|
2025
Q3 | $9.94M | Buy |
389,938
+370,510
| +1,907% | +$9.14M | 0.09% | 151 |
|
|
2025
Q2 | $471K | Sell |
19,428
-24,914
| -56% | -$581K | 0.01% | 983 |
|
|
2025
Q1 | $1.12M | Buy |
44,342
+27,467
| +163% | +$719K | 0.03% | 422 |
|
|
2024
Q4 | $448K | Buy |
16,875
+14,244
| +541% | +$386K | 0.01% | 897 |
|
|
2024
Q3 | $76.1K | Sell |
2,631
-52,263
| -95% | -$1.52M | ﹤0.01% | 1980 |
|
|
2024
Q2 | $1.54M | Buy |
54,894
+34,515
| +169% | +$950K | 0.03% | 555 |
|
|
2024
Q1 | $566K | Buy |
+20,379
| New | +$565K | 0.01% | 925 |
|
|
2023
Q4 | – | Sell |
-495
| Closed | -$15K | – | 2135 |
|
|
2023
Q3 | $16.4K | Buy |
+495
| New | +$17.5K | ﹤0.01% | 1644 |
|
|
2023
Q2 | – | Sell |
-8,946
| Closed | -$365K | – | 1907 |
|
|
2023
Q1 | $365K | Buy |
+8,946
| New | +$386K | 0.01% | 968 |
|
|
2022
Q4 | – | Sell |
-6,199
| Closed | -$297K | – | 1575 |
|
|
2022
Q3 | $271K | Buy |
6,199
+4,175
| +206% | +$203K | 0.01% | 1080 |
|
|
2022
Q2 | $106K | Sell |
2,024
-11,611
| -85% | -$592K | ﹤0.01% | 1418 |
|
|
2022
Q1 | $706K | Sell |
13,635
-361,145
| -96% | -$18.7M | 0.01% | 839 |
|
|
2021
Q4 | $22.1M | Buy |
374,780
+353,285
| +1,644% | +$17.5M | 0.46% | 38 |
|
|
2021
Q3 | $923K | Buy |
21,495
+11,502
| +115% | +$510K | 0.06% | 365 |
|
|
2021
Q2 | $391K | Sell |
9,993
-2,959
| -23% | -$115K | 0.01% | 929 |
|
|
2021
Q1 | $469K | Sell |
12,952
-56,123
| -81% | -$1.99M | 0.02% | 598 |
|
|
2020
Q4 | $2.54M | Sell |
69,075
-46,968
| -40% | -$1.72M | 0.1% | 124 |
|
|
2020
Q3 | $4.04M | Sell |
116,043
-32,437
| -22% | -$1.14M | 0.27% | 64 |
|
|
2020
Q2 | $4.61M | Sell |
148,480
-165,591
| -53% | -$5.63M | 0.28% | 49 |
|
|
2020
Q1 | $9.73M | Buy |
314,071
+265,529
| +547% | +$9.05M | 0.44% | 26 |
|
|
2019
Q4 | $1.8M | Buy |
48,542
+34,915
| +256% | +$1.24M | 0.09% | 212 |
|
|
2019
Q3 | $464K | Buy |
+13,627
| New | +$496K | 0.03% | 353 |
|
|
2018
Q4 | – | Sell |
-10,055
| Closed | -$417K | – | 276 |
|
|
2018
Q3 | $420K | Buy |
+10,055
| New | +$387K | 0.04% | 141 |
|
Other funds holding PFE
Centiva Capital's PFE Position: Q2 2026 in Review
Centiva Capital increased its Pfizer (PFE) stake by 74% in Q2 2026, buying an estimated $10M and bringing the position to 899,074 shares worth $21.6M. The position accounts for 0.19% of the portfolio, ranked #98.
Centiva Capital first reported a position in PFE in Q3 2018 and has held it in 26 quarters since. The position peaked at $22.1M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Centiva Capital held 899,074 shares of Pfizer worth $21.6M as of Q2 2026.
- Centiva Capital bought 383,579 Pfizer shares in Q2 2026, an estimated $10M.
- Pfizer made up 0.19% of Centiva Capital's portfolio in Q2 2026, its #98 holding.
- Centiva Capital first reported a position in Pfizer in Q3 2018 and has held it in 26 quarters since.
- Centiva Capital's Pfizer position peaked at $22.1M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.